ArticleAbdominal radiology (New York)2026
Preoperative prediction of lymph node metastasis in endometrial carcinoma based on MRI radiomic, clinical, and sonographic features: a clinical dual-center study.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo explore MRI-based radiomic, clinical, and sonographic features for constructing models to predict lymph node metastasis (LNM) in endometrial carcinoma (EC) preoperatively and noninvasively.
methodsFrom January 2016 to December 2024, clinical, imaging and pathological information of patients with EC were retrospectively collected at center 1 and 2. Radiomic features extracted from preoperative MRI were screened, a radiomic model was developed and radscore was calculated. Univariate and multivariate analyses were performed with all features to identify independent LNM predictors. Another three models were constructed: a clinical model based on clinical features, an ultrasound model based on features defined by International Endometrial Tumor Analysis, and a combined model integrating all predictors. Receiver operator characteristic curve and DeLong test were employed for evaluating model performance. Clinical decision curve (CDC) and calibration curve were used for assessing the clinical benefit of the models.
results225 patients with EC were included, in which 44 patients were with LNM and 181 patients were without LNM. Statistical analyses showed that radscore, age, CA125, and endometrium thickness (EMT) were predictors for LNM. DeLong test demonstrated that CombinedModel had the superior predictive performance, which was presented as a nomogram, with area under the curve values of 0.895 (95%CI:0.828,0.961),0.870 (95%CI:0.739,1.000), 0.890 (95%CI: 0.766,1.000) for training, internal and external validation set, respectively. CDC and calibration curve of the nomogram demonstrated higher clinical benefit than other models.
conclusionThe nomogram comprising age, CA125, radscore, and EMT exhibited the best performance in LNM prediction of patients with EC, making it a valuable tool for decision-making.
Indexed as
Identifiers
42138747What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.